NorthStar Medical Radioisotopes, LLC

NorthStar develops, manufactures and distributes radioisotopes that are used daily for patients needing medically important diagnostic imaging tests. Our novel, high technology approaches have enabled NorthStar to be the first company in nearly 30 years to produce the radioisotope Mo-99 in the United States. NorthStar’s processes are non-uranium based and designed to help minimize waste while meeting the highest quality standards. The Mo-99 is used in NorthStar’s RadioGenix® System, an isotope separation platform used by radiopharmacies across the country to produce the imaging radioisotope Tc-99m. NorthStar will scale-up production over the coming months and years and intends to become the industry’s market leader. Beyond Mo-99, we have a pipeline of other novel and medically important isotopes which can further grow our business, and provide development opportunities for our employees.Working with this novel and advanced technology is challenging yet rewarding for talented individuals who want to make a difference and be part of an exciting and rapidly growing business. NorthStar’s people drive our solutions and our success, and we are committed to ensuring that we provide fulfilling work experiences and valuable development opportunities.